evening primrose oil, EPO
HD0143
Oenothera biennis L.; Oenothera lamarckiana L.
N/A
Skin disorders & minor wounds
Oenothera biennis, the common evening-primrose, is a species of flowering plant in the family Onagraceae, native to eastern and central North America, from Newfoundland west to Alberta, southeast to Florida, and southwest to Texas, and widely naturalized elsewhere in temperate and subtropical regions. Evening primrose oil (EPO) is produced from the plant.Other common names include evening star, sundrop, weedy evening primrose, German rampion, hog weed, King's cure-all and fever-plant.
Level 0 (No convinced report of liver injury caused by herbal and dietary supplement)
N/A
The evening primrose was introduced to Europe in the early 17th century as an ornamental plant in botanical gardens, without recognition of their ancient use as medicine. However, indigenous tribes in North America (namely the Cherokee, Iroquois, Ojibwe and Potawatomi) were using the plant as food and medicinal crop for hundreds of years. Today, the evening primrose is mainly known as garden plant and as medicinal plant in specialized sectors. However, almost all parts of the evening primrose are edible and medically or cosmetically applicable. This includes the roots, leaves, blossoms, flower buds and seeds. (Source: Wiki)
The oil of mature seeds contains approximately 7–10% GLA. GLA, also referred to as C18:3-ω6 fatty acid, is not an essential fatty acid because it can readily be created from linoleic acid (C18:2-ω6). GLA is a preliminary stage in the production of prostaglandin, which is essential for the proper functioning of a cell. Symptoms and diseases like endogenous eczema, the Sjögren-syndrome, premenstrual syndrome (PMS), polyarthritis, multiple sclerosis and menopausal symptoms can be induced by a prostaglandin shortage. In theory, an additional intake of GLA might help to cure these symptoms.The Cochrane Collaboration conducted a meta-analysis of clinical trials studying the effect of orally administered EPO on eczema and concluded that there was no effect. The Mayo Clinic examined evidence for the safety and effectiveness of evening primrose for several conditions; it was considered that there was "good evidence" (grade B, vs "strong evidence", grade A) that it produced a moderate improvement in eczema. Grade C, "unclear", evidence for benefit is listed for other conditions. Research has shown a lack of significant beneficial effects on heart functions. Many conditions for which evening primrose oil is a traditional remedy or there is a theory suggesting efficacy are listed by the Mayo Clinic without comment.There are conflicting opinions and evidence for the medicinal effects of GLA. The active constituent of EPO, which has been promoted to treat ailments including breast pain and eczema; such marketing was described by the British Medical Journal (BMJ) as ethically dubious – the substance was likely to be remembered as "a remedy for which there is no disease". Another single source suggests that Evening Primrose Oil with adjuvant vitamin E, may reduce breast pain. The BMJ said in 2003 that it was of no use in atopic dermatitis. The American Cancer Society said in 2010 that there was very little evidence for its effectiveness as an anti-cancer agent, for which it is sometimes promoted, and "neither GLA nor other GLA-rich supplements (such as evening primrose oil) have been convincingly shown to be useful in preventing or treating any other health conditions." (Source: Wiki)